Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of Apatinib Combined With
Vinorelbine Used for Driver Gene Mutation Negative Third-line and Third-line Posterior
Advanced Non-small Cell Lung Cancer